Search Results 631-640 of 16994 for Galactose

  1. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

  2. A Study to Assess Characteristics of the Aorta Artery Using Heart Echo - Mayo Clinic

    The purpose of this study is to measure the characteristics of the walls of an enlarged aortic blood vessel using non-invasive heart echo to help predict how ...

  3. Coagulation factor ix recombinant, glycopegylated (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is to be given only by or under the supervision of your doctor or other health care professional. This product is available in the following ...

  4. Stress Management for Couples Undergoing In Vitro Fertilization (IVF) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Primary Hyperoxaluria Mutation Genotyping/Phenotyping - Mayo Clinic

    About this study. Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.

  7. The Effects of Acute and Chronic Exercise on the Immune Phenotype in Healthy Patients - Mayo Clinic

    We are doing this study to compare how acute maximal and acute endurance exercise affect immune cell populations in the blood for different populations of ...

  8. A Study to Evaluate the Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations - Mayo Clinic

    We will draw a simple random sample of OCHC patients (N=1000, age 18+) with 1:1 randomization of communication about COVID-19 and availability of rapid testing ...

  9. Motion Sickness Archives - Mayo Clinic News Network

  10. Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies - Mayo Clinic

    About this study. This is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single agent in ...